drugset / Trial / NCT01776437
Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers
RandomizedCrossoverOpen-labelOther
Summary
This is a randomized, 2-period, 2-sequence crossover study to evaluate the effect of food on the relative bioavailability of BMN 673 during fasting and fed conditions in healthy male subjects.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-05
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talazoparib | Small molecule | 500 ug | — |
Indications
No indication recorded.